These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7997766)

  • 1. [Cardiac arrhythmia with oral oxamniquine use in the schistosomiasis mansoni treatment].
    Guitti JC; Gordan LN; Baldy JL
    Rev Inst Med Trop Sao Paulo; 1993; 35(6):585-7. PubMed ID: 7997766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Schistosoma mansoni infection with oxamniquine in Riyadh, Saudi Arabia.
    Al-Aska AK
    Trop Med Parasitol; 1985 Dec; 36(4):213-4. PubMed ID: 3937212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary clinical trial of oral oxamniquine in the treatment of Schistosoma mansoni in children in Ethiopia.
    Ayele T
    East Afr Med J; 1986 Apr; 63(4):291-4. PubMed ID: 3089756
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of schistosomiasis mansoni using oral oxamniquine].
    Domingues AL; Coutinho A
    Rev Inst Med Trop Sao Paulo; 1975; 17(3):164-80. PubMed ID: 1135569
    [No Abstract]   [Full Text] [Related]  

  • 5. A case of Schistosoma mansoni infection treated during the prepatent period.
    Enk MJ; Katz N; Zech Coelho PM
    Nat Clin Pract Gastroenterol Hepatol; 2008 Feb; 5(2):112-5. PubMed ID: 18253140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re: serious side effects of oxamniquine during the treatment of Schistosoma mansoni in Kenya.
    Okela GB
    East Afr Med J; 1985 Jul; 62(7):433. PubMed ID: 3935408
    [No Abstract]   [Full Text] [Related]  

  • 7. Field use of oral oxamniquine in the treatment of S. mansoni.
    Eyakuze VM; Rutasitara WK; Ndalahwa JB
    East Afr Med J; 1979 Jan; 56(1):22-5. PubMed ID: 436702
    [No Abstract]   [Full Text] [Related]  

  • 8. A field evaluation of three dose levels of oxamniquine in Gezira--Sudan.
    Abdel-Rahim IM; Haridi AA; Abdel-Hameed AA
    East Afr Med J; 1988 Nov; 65(11):771-7. PubMed ID: 3150352
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical trials with oxamniquine, by oral route, in schistosomiasis mansoni.
    Katz N; Grinbaum E; Chaves A; Zicker F; Pellegrino J
    Rev Inst Med Trop Sao Paulo; 1976; 18(5):371-7. PubMed ID: 794980
    [No Abstract]   [Full Text] [Related]  

  • 10. A fifteen-month study on the efficacy of a single 15 mg/kg dose of oxamniquine (Vansil) in Schistosoma mansoni in an endemic area.
    Nozais JP
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):52-7, 168-74. PubMed ID: 6256843
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infection: a controlled trial.
    Ferrari ML; Coelho PM; Antunes CM; Tavares CA; da Cunha AS
    Bull World Health Organ; 2003; 81(3):190-6. PubMed ID: 12764515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seizures associated with oxamniquine therapy.
    Stokvis H; Bauer AG; Stuiver PC; Malcolm AD; Overbosch D
    Am J Trop Med Hyg; 1986 Mar; 35(2):330-1. PubMed ID: 3082231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Field experiences with oral oxamniquine in the treatment of schistosomiasis mansoni.
    Coura JR; Argento CA; Conceição MJ; Lewis EM; dos Santos ML; Magalhães P
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):77-84, 195-202. PubMed ID: 7455514
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral oxamniquine in the treatment of persistent Schistosoma mansoni bilharziasis.
    Blair DM; Weber MC
    Cent Afr J Med; 1975 Feb; 21(2):24-6. PubMed ID: 1122549
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined praziquantel-oxamniquine treatment of schistosomiasis: synergy in low dosage.
    Pugh RN
    Trans R Soc Trop Med Hyg; 1991; 85(5):699. PubMed ID: 1815568
    [No Abstract]   [Full Text] [Related]  

  • 16. Observations of the treatment of mansoni schistosomiasis with oxamniquine: efficacy in children and in persistent salmonellosis; resistance of a strain of Schistosoma mansoni; hepatic toxicity and neurological side effects.
    Pedro Rde J; de Souza Dias LC; Amato Neto V; de Carvalho SA
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):32-6, 148-52. PubMed ID: 7455507
    [No Abstract]   [Full Text] [Related]  

  • 17. [Trial schistosomiasis control in an endemic area by 4 mass treatments of the population].
    Silva AE; Rocha L; Castro CN; Prata A
    Rev Inst Med Trop Sao Paulo; 1981; 23(6):260-3. PubMed ID: 7345537
    [No Abstract]   [Full Text] [Related]  

  • 18. Serious side effects of oxamniquine during the treatment of Schistosoma mansoni in Kenya.
    Chunge CN; Kimani RG; Gachihi G; Mkoji G; Kamau T; Rashid JR
    East Afr Med J; 1985 Jan; 62(1):3-4. PubMed ID: 4006813
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical development of oxamniquine in Egypt.
    Saif M; Gaber A
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):18-27, 134-43. PubMed ID: 7455504
    [No Abstract]   [Full Text] [Related]  

  • 20. The efficacy of oxamniquine in selective population chemotherapy in Ethiopia.
    Birrie H; Abebe F; Ayele T
    Ethiop Med J; 1995 Oct; 33(4):235-41. PubMed ID: 8674489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.